Join
Live feed
·
PRReleasevia Quantisnow
Organogenesis Holdings Inc. logo

Organogenesis Announces FDA Acceptance of Biologics License Application for ReNu® for the Management of Symptomatic Knee Osteoarthritis

ByQuantisnow·Wall Street's wire, on your screen.
ORGO· Organogenesis Holdings Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ORGO (Organogenesis Holdings Inc.) and more on Quantisnow.